About this trial

The research will be retrospective, and will include all patients who were admitted during 2020 and 2021 in the COVID-19 ICU of University Hospital Center Osijek due to pneumonia caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The association of chest x-ray infiltrate evolution with changes in laboratory inflammatory parameters and respiratory function parameters will be examined.

Eligibility criteria

Qualifiers

Pneumonia caused by SARS-CoV-2 virus

Admission to the ICU COVID-19 unit

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Chest X-ray

Treatment groups

200 Participants
are divided into 1 treatment group

Locations

1
University hospital Osijek31000, Osijek Croatia

Sponsors and collaborators

Osijek University Hospital

Lead sponsor